Загрузка...
A retrospective six-patient series of apatinib for the treatment of persistent or recurrent carcinoma of the cervix
OBJECTIVE: Although advances have been made in the clinical and therapeutic management of women with cervical cancer, the best treatment for patients with metastatic or recurrent cervical cancer is still undefined. Apatinib, a novel inhibitor of vascular endothelial growth factor receptor-2 tyrosine...
Сохранить в:
| Опубликовано в: : | Onco Targets Ther |
|---|---|
| Главные авторы: | , , , , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Dove
2019
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6643513/ https://ncbi.nlm.nih.gov/pubmed/31410025 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/OTT.S212536 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|